0001193125-21-150695.txt : 20210505 0001193125-21-150695.hdr.sgml : 20210505 20210505061202 ACCESSION NUMBER: 0001193125-21-150695 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210504 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INNOSPEC INC. CENTRAL INDEX KEY: 0001054905 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 981081725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13879 FILM NUMBER: 21891037 BUSINESS ADDRESS: STREET 1: 8310 SOUTH VALLEY HIGHWAY STREET 2: SUITE 350 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 303-566-0528 MAIL ADDRESS: STREET 1: 8310 SOUTH VALLEY HIGHWAY STREET 2: SUITE 350 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: OCTEL CORP DATE OF NAME CHANGE: 19980209 8-K 1 d178848d8k.htm 8-K 8-K
false 0001054905 0001054905 2021-05-04 2021-05-04

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 4, 2021

 

 

INNOSPEC INC.

(Exact name of registrant as specified in its charter)

 

 

Commission File Number: 1-13879

 

Delaware   98-0181725
(State or other jurisdiction
of incorporation)
  (IRS Employer
Identification No.)

8310 South Valley Highway, Suite 350

Englewood, Colorado, 80112

(Address of principal executive offices, including zip code)

(303)792-5554

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of exchange
on which registered

Common Stock   IOSP   NASDAQ

 

 

 


Item 2.02

Results of Operations and Financial Condition.

On May 4, 2021, Innospec Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended March 31, 2021 (the “Press Release”).

 

Item 7.01

Regulation FD Disclosure

The Press Release also announced that on April 28, 2021, the Company’s Board of Directors declared a semi-annual dividend of $0.57 per share on the Company’s common stock (IOSP). The dividend will be paid on May 26, 2021 to holders of record on May 17, 2021.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

EXHIBIT INDEX

 

Number   

Description

  

Method of Filing

99.1    Press Release dated May 4, 2021 announcing Innospec Inc.’s financial results for the fiscal quarter ended March 31, 2021    Filed Herewith
104    Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      INNOSPEC INC.  
Date: May 5, 2021     By:  

/s/ David B. Jones

 
      David B. Jones  
      Vice President, General Counsel and Chief Compliance Officer  
EX-99.1 2 d178848dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

 

LOGO

PRESS RELEASE

INNOSPEC REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS

Record sales and operating income in Performance Chemicals

Continued recovery in Fuel Specialties and Oilfield Services

Strong cash generation and excellent liquidity position; Improvement in net cash to $116.6 million

GAAP EPS $0.94 and adjusted non-GAAP EPS of $1.06 reduced by 14 cents from higher share-based compensation

Semi-annual dividend increased 10 percent to 57 cents per share

Englewood, CO – May 4, 2021 – Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the first quarter ended March 31, 2021. The Company also announced the declaration of its semi-annual dividend of $0.57 per common share for the first half of 2021, representing an increase of 10 percent. This dividend will be paid on May 26, 2021, to shareholders of record on May 17, 2021.

Total revenues for the first quarter were $339.6 million, a decrease of 9 percent from $372.3 million in the corresponding period last year. Net income for the quarter was $23.4 million or 94 cents per diluted share compared to $33.1 million or $1.34 per diluted share, recorded a year ago. EBITDA for the quarter was $41.4 million compared to $56.7 million reported in the same period a year ago.

Results for this quarter include some special items, which are summarized in the table below. Excluding these items, adjusted non-GAAP EPS in the first quarter was $1.06 per diluted share, compared to $1.42 per diluted share a year ago.

Cash generation for the quarter was positive with net cash from operating activities of $22.7 million before capital expenditures of $10.3 million in the quarter. We closed the quarter with net cash of $116.6 million.

EBITDA, income before income taxes and net income excluding special items, and related per-share amounts, are non-GAAP financial measures that are defined and reconciled with GAAP results herein and in the schedules below.

 

     Quarter ended March 31, 2021     Quarter ended March 31, 2020  

(in millions, except share and per share data)

   Income
before

income
taxes
    Net
income
    Diluted
EPS
    Income
before

income
taxes
    Net
income
    Diluted
EPS
 

Reported GAAP amounts

   $ 30.8     $ 23.4     $ 0.94     $ 44.2     $ 33.1     $ 1.34  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Amortization of acquired intangible assets

     3.7       3.0       0.12       4.6       3.6       0.15  

Foreign currency exchange gains

     (1.6     (1.2     (0.05     (2.5     (1.9     (0.08

Legacy costs of closed operations

     0.9       0.7       0.03       —         —         —    

Acquisition related costs

     0.8       0.6       0.02       —         —         —    

Adjustment of income tax provisions

     —         —         —         —         0.2       0.01  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     3.8       3.1       0.12       2.1       1.9       0.08  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted non-GAAP amounts

   $ 34.6     $ 26.5     $ 1.06     $ 46.3     $ 35.0     $ 1.42  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


Commenting on the first quarter results, Patrick S. Williams, President and Chief Executive Officer, said,

“This was another pleasing quarter with further sequential sales growth in all of our businesses. Sales in Performance Chemicals reached a record while sales in Fuel Specialties and Oilfield Services advanced sequentially in their post-COVID-19 recovery. Cash generation was again excellent, and we increased our semi-annual dividend payment by 10 percent.

Despite the headwind of economic restrictions and vaccination delays in Europe, Performance Chemicals delivered record quarterly operating income up an impressive 17 percent over the prior year. We are pulling forward organic growth investments which enable less single-use packaging and milder and more natural formulations. This resulted in the authorization during the quarter of $10.0 million in new capital projects which are incremental to our original 2021 plans.

In Fuel Specialties, sales for the first quarter were 5 percent below last year. Global demand for refined fuel products continues to improve but is still below pre-COVID-19 levels. Demand for aviation fuel still lags well behind other transportation fuels. As global oil demand continues to recover, higher volumes should benefit margins as leverage on fixed manufacturing and overhead costs improves. In addition, we expect margins to be supported by a better sales mix as demand for our aviation additives continues to increase over the coming year.

In Oilfield Services sales and operating income continued to grow sequentially despite the US winter storm event which impacted certain oilfield activites during a two week period in February 2021. Sequential sales grew by 28 percent, gross margins remained in the expected range and operating leverage continued to improve. Moving into the second quarter, we currently expect to see additional improvement in activity levels and demand for our products and services.

The pickup in economic activity over the past two quarters has strained the global supply chain. Port delays and regional shipping container shortages in addition to one-off events like the US winter storm and the Suez Canal blockage have led to widespread force majeure declarations in the global chemical industry.

To date our supply chain, manufacturing and sales teams have done an excellent job managing through this environment. In addition to keeping our customers supplied, we have implemented price increases across all our businesses to offset raw material and freight cost inflation due to the above mentioned supply-demand imbalances.”

Revenues in Fuel Specialties were $139.3 million for the quarter, a 5 percent decrease from $147.0 million last year. Volumes fell by 7 percent and there was a negative price/mix impact of 3 percent offsetting a 5 percent positive currency impact. Gross margins of 32.2 percent were at the lower end of our expected range and 2.6 percentage points below the same quarter last year. Operating income for the quarter was $23.8 million, compared to $32.1 million in the same quarter last year.

Revenues in Performance Chemicals reached a record of $125.9 million, up 11 percent from $113.1 million in the first quarter last year. Volume growth of 7 percent and a positive currency impact of 6 percent were partially offset by an adverse price/mix impact of 2 percent. Gross margins improved by 0.5 percentage points from the same quarter last year to 24.9 percent. Operating income reached a record of $18.3 million, up 17 percent from $15.6 million a year ago.

Revenues in Oilfield Services for the quarter were $74.4 million, down 34 percent from $112.2 million in the first quarter last year driven by low levels of US completions activity, but momentum continued on a sequential basis with sales up 28 percent. Gross margins improved by 0.6 percentage points from the same quarter last year to 32.9 percent. Operating income of $1.2 million was down from $7.2 million in the same quarter last year but was a substantial improvement over the $0.2 million in the fourth quarter of 2020.

Corporate costs for the quarter were $15.1 million, compared with $12.8 million a year ago, due mainly to higher personnel-related expenses driven by increased share-based compensation accruals following the 13 percent uplift in our share price over the quarter.

The effective tax rate for the quarter was 24.0 percent, compared to 25.1 percent in the same quarter last year.

For the quarter, net cash provided by operating activities was $22.7 million, compared to $2.4 million a year ago. As of March 31, 2021, Innospec had $117.0 million in cash and cash equivalents, and finance lease debt of $0.4 million, resulting in a net cash position of $116.6 million.


Mr. Williams concluded,

“We are very pleased with the start to this year, and over the coming quarters we expect to see continued improvement in overall market conditions as the post-COVID-19 economic re-opening progresses. Improving demand conditions coupled with supply-chain tightening is driving cost inflation which we are managing through price action where required and close collaboration with our customers.

In terms of capital allocation, we have begun to pull forward incremental organic growth capital expenditures to support existing demand in Performance Chemicals and have significant balance sheet capacity to pursue complementary acquisition opportunities for this business. In addition, we expect to complete our third expansion in production capacity for our proprietary, energy saving, drag reducing agents (DRA) technology at our Texas plant by Q3 2021.

We believe that Innospec is well positioned for the recovery in global economic activity in 2021. Supported by our strong cash flow generation, I am also pleased that our Board has approved a 10 percent increase in our semi-annual dividend to 57 cents per share, continuing our record of returning value to shareholders.”

Use of Non-GAAP Financial Measures

The information presented in this press release includes financial measures that are not calculated or presented in accordance with Generally Accepted Accounting Principles in the United States (GAAP). These non-GAAP financial measures comprise EBITDA, income before income taxes excluding special items, net income excluding special items and related per share amounts together with net cash. EBITDA is net income per our consolidated financial statements adjusted for the exclusion of charges for interest expense, net, income taxes, depreciation, and amortization. Income before income taxes, net income and diluted EPS, excluding special items, per our consolidated financial statements are adjusted for the exclusion of amortization of acquired intangible assets, foreign currency exchange gains, legacy costs of closed operations, acquisition related costs and adjustment of income tax provisions. Net cash is cash and cash equivalents less total debt. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided herein and in the schedules below. The Company believes that such non-GAAP financial measures provide useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, these non-GAAP measures address questions the Company routinely receives from analysts and investors and the Company has determined that it is appropriate to make this data available to all investors. While the Company believes that such measures are useful in evaluating the Company’s performance, investors should not consider them to be a substitute for financial measures prepared in accordance with GAAP. In addition, these non-GAAP financial measures may differ from similarly-titled non-GAAP financial measures used by other companies and do not provide a comparable view of the Company’s performance relative to other companies in similar industries. Management uses adjusted EPS (the most directly comparable GAAP financial measure for which is GAAP EPS) and adjusted net income and EBITDA (the most directly comparable GAAP financial measure for which is GAAP net income) to allocate resources and evaluate the performance of the Company’s operations. Management believes the most directly comparable GAAP financial measure is GAAP net income and has provided a reconciliation of EBITDA and net income excluding special items, and related per share amounts, to GAAP net income herein and in the schedules below.

About Innospec Inc.

Innospec Inc. is an international specialty chemicals company with approximately 1900 employees in 24 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil and gas exploration and production industry. The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets.


Forward-Looking Statements

This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “could,” “believes,” “feels,” “plan,” “intend” or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, including, the effects of the COVID-19 pandemic, such as its duration, its unknown long-term economic impact, measures taken by governmental authorities to address it and the manner in which the pandemic may precipitate or exacerbate other risks and/or uncertainties, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2020 and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading “Risk Factors” in such reports. Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

Contacts:

Corbin Barnes

Innospec Inc.

+44-151-355-3611

corbin.barnes@innospecinc.com


INNOSPEC INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Schedule 1

 

(in millions, except share and per share data)

   Three Months Ended
March 31
 
   2021     2020  

Net sales

   $ 339.6     $ 372.3  

Cost of goods sold

     (238.8     (258.4
  

 

 

   

 

 

 

Gross profit

     100.8       113.9  

Operating expenses:

    

Selling, general and administrative

     (63.6     (64.4

Research and development

     (9.0     (8.6
  

 

 

   

 

 

 

Total operating expenses

     (72.6     (73.0
  

 

 

   

 

 

 

Operating income

     28.2       40.9  

Other income, net

     3.0       3.9  

Interest expense, net

     (0.4     (0.6
  

 

 

   

 

 

 

Income before income taxes

     30.8       44.2  

Income taxes

     (7.4     (11.1
  

 

 

   

 

 

 

Net income

   $ 23.4     $ 33.1  
  

 

 

   

 

 

 

Earnings per share:

    

Basic

   $ 0.95     $ 1.35  

Diluted

   $ 0.94     $ 1.34  

Weighted average shares outstanding (in thousands):

    

Basic

     24,601       24,529  

Diluted

     24,840       24,742  


INNOSPEC INC. AND SUBSIDIARIES

Schedule 2A

 

SEGMENTAL ANALYSIS OF RESULTS    Three Months Ended
March 31
 

(in millions)

   2021     2020  

Net sales:

    

Fuel Specialties

   $ 139.3     $ 147.0  

Performance Chemicals

     125.9       113.1  

Oilfield Services

     74.4       112.2  
  

 

 

   

 

 

 
     339.6       372.3  
  

 

 

   

 

 

 

Gross profit/(loss):

    

Fuel Specialties

     44.9       51.2  

Performance Chemicals

     31.4       27.6  

Oilfield Services

     24.5       36.2  

Octane Additives

     —         (1.1
  

 

 

   

 

 

 
     100.8       113.9  
  

 

 

   

 

 

 
Operating income/(loss):     

Fuel Specialties

     23.8       32.1  

Performance Chemicals

     18.3       15.6  

Oilfield Services

     1.2       7.2  

Octane Additives

     —         (1.2

Corporate costs

     (15.1     (12.8
  

 

 

   

 

 

 

Total operating income

   $ 28.2     $ 40.9  
  

 

 

   

 

 

 

Schedule 2B

 

NON-GAAP MEASURES    Three Months Ended
March 31
 

(in millions)

   2021     2020  

Net income

   $ 23.4     $ 33.1  

Interest expense, net

     0.4       0.6  

Income taxes

     7.4       11.1  

Depreciation and amortization:

    

Fuel Specialties

     1.3       1.0  

Performance Chemicals

     5.4       5.0  

Oilfield Services

     3.1       4.3  

Octane Additives

     —         0.3  

Corporate costs

     0.4       1.3  
  

 

 

   

 

 

 

EBITDA

     41.4       56.7  
  

 

 

   

 

 

 

EBITDA:

    

Fuel Specialties

     25.1       33.1  

Performance Chemicals

     23.7       20.6  

Oilfield Services

     4.3       11.5  

Octane Additives

     —         (0.9

Corporate costs

     (14.7     (11.5
  

 

 

   

 

 

 
     38.4       52.8  

Other income, net

     3.0       3.9  
  

 

 

   

 

 

 

EBITDA

   $ 41.4     $ 56.7  
  

 

 

   

 

 

 

EBITDA by segment includes operating income relating to the segments, excluding depreciation and amortization.


Schedule 3

INNOSPEC INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

(in millions)

   March 31,
2021
     December 31,
2020
 

Assets

 

  

Current assets:

     

Cash and cash equivalents

   $ 117.0      $ 105.3  

Trade and other accounts receivable

     247.9        221.4  

Inventories

     223.1        220.0  

Prepaid expenses

     12.3        14.9  

Prepaid income taxes

     5.0        4.2  

Other current assets

     2.3        0.4  
  

 

 

    

 

 

 

Total current assets

     607.6        566.2  

Net property, plant and equipment

     209.9        210.8  

Goodwill

     367.2        371.2  

Operating lease right-of-use assets

     36.7        40.1  

Other intangible assets

     70.2        75.3  

Deferred tax assets

     7.4        7.6  

Pension asset

     119.6        118.0  

Other non-current assets

     7.5        8.2  
     
  

 

 

    

 

 

 

Total assets

   $ 1,426.1      $ 1,397.4  
  

 

 

    

 

 

 

Liabilities and Stockholders’ Equity

     

Current liabilities:

     

Accounts payable

   $ 114.5      $ 98.7  

Accrued liabilities

     131.8        129.8  

Current portion of finance leases

     0.4        0.5  

Current portion of plant closure provisions

     6.6        6.6  

Current portion of accrued income taxes

     8.8        5.5  

Current portion of operating lease liabilities

     12.2        11.3  
  

 

 

    

 

 

 

Total current liabilities

     274.3        252.4  

Finance leases, net of current portion

     —          0.1  

Plant closure provisions, net of current portion

     51.3        51.9  

Accrued income taxes, net of current portion

     32.4        32.4  

Unrecognized tax benefits

     16.0        16.0  

Operating lease liabilities, net of current portion

     24.6        28.9  

Deferred tax liabilities

     46.5        46.9  

Pension liabilities and post-employment benefits

     19.5        20.5  

Other non-current liabilities

     2.4        3.4  

Equity

     959.1        944.9  
  

 

 

    

 

 

 

Total liabilities and equity

   $ 1,426.1      $ 1,397.4  
  

 

 

    

 

 

 


Schedule 4

INNOSPEC INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

     Three Months Ended
March 31
 

(in millions)

   2021     2020  

Cash Flows from Operating Activities

    

Net income

   $ 23.4     $ 33.1  

Adjustments to reconcile net income to cash provided by operating activities:

    

Depreciation and amortization

     10.3       12.0  

Deferred taxes

     0.1       0.7  

Non-cash movements on defined benefit pension plans

     (0.8     (1.2

Stock option compensation

     1.6       1.2  

Changes in working capital

     (13.6     (46.8

Movements in accrued income taxes

     3.7       1.6  

Movements in plant closure provisions

     (0.2     0.1  

Movements in other assets and liabilities

     (1.8     1.7  
  

 

 

   

 

 

 

Net cash provided by operating activities

     22.7       2.4  

Cash Flows from Investing Activities

    

Capital expenditures

     (10.3     (7.8
  

 

 

   

 

 

 

Net cash used in investing activities

     (10.3     (7.8

Cash Flows from Financing Activities

    

Non-controlling interest

     —         0.1  

Repayment of finance leases

     (0.2     (0.3

Issue of treasury stock

     0.5       0.7  

Repurchase of common stock

     (0.6     (2.1
  

 

 

   

 

 

 

Net cash used in financing activities

     (0.3     (1.6

Effect of foreign currency exchange rate changes on cash

     (0.4     (0.6
  

 

 

   

 

 

 

Net change in cash and cash equivalents

     11.7       (7.6

Cash and cash equivalents at beginning of period

     105.3       75.7  
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 117.0     $ 68.1  
  

 

 

   

 

 

 

Amortization of deferred finance costs of $0.1 million (2020 - $0.1 million) are included in depreciation and amortization in the condensed consolidated statements of cash flows and in interest expense, net in the condensed consolidated statements of income.

EX-101.SCH 3 iosp-20210504.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 iosp-20210504_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Incorporation State Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 5 iosp-20210504_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g178848g99q30.jpg GRAPHIC begin 644 g178848g99q30.jpg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end XML 7 d178848d8k_htm.xml IDEA: XBRL DOCUMENT 0001054905 2021-05-04 2021-05-04 false 0001054905 8-K 2021-05-04 INNOSPEC INC. 1-13879 DE 98-0181725 8310 South Valley Highway Suite 350 Englewood CO 80112 (303) 792-5554 false false false false false Common Stock IOSP NASDAQ XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Document and Entity Information
May 04, 2021
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001054905
Document Type 8-K
Document Period End Date May 04, 2021
Entity Registrant Name INNOSPEC INC.
Entity File Number 1-13879
Entity Incorporation State Country Code DE
Entity Tax Identification Number 98-0181725
Entity Address, Address Line One 8310 South Valley Highway
Entity Address, Address Line Two Suite 350
Entity Address, City or Town Englewood
Entity Address, State or Province CO
Entity Address, Postal Zip Code 80112
City Area Code (303)
Local Phone Number 792-5554
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Security 12b Title Common Stock
Trading Symbol IOSP
Security Exchange Name NASDAQ
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 95 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d178848d8k.htm d178848dex991.htm iosp-20210504.xsd iosp-20210504_lab.xml iosp-20210504_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d178848d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d178848d8k.htm" ] }, "labelLink": { "local": [ "iosp-20210504_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "iosp-20210504_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "iosp-20210504.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "iosp", "nsuri": "http://www.innospecinc.com/20210504", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d178848d8k.htm", "contextRef": "duration_2021-05-04_to_2021-05-04", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d178848d8k.htm", "contextRef": "duration_2021-05-04_to_2021-05-04", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.innospecinc.com//20210504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001193125-21-150695-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-150695-xbrl.zip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